TWi Biotechnology (ROCO:6610) Accounts Payable & Accrued Expense : NT$46.30 Mil (As of Jun. 2024)

View and export this data going back to 2016. Start your Free Trial

What is TWi Biotechnology Accounts Payable & Accrued Expense?

TWi Biotechnology's quarterly accounts payable & accrued expense increased from Jun. 2023 (NT$21.51 Mil) to Dec. 2023 (NT$44.77 Mil) and increased from Dec. 2023 (NT$44.77 Mil) to Jun. 2024 (NT$46.30 Mil).

TWi Biotechnology's annual accounts payable & accrued expense declined from Dec. 2021 (NT$24.32 Mil) to Dec. 2022 (NT$22.85 Mil) but then increased from Dec. 2022 (NT$22.85 Mil) to Dec. 2023 (NT$44.77 Mil).

TWi Biotechnology Accounts Payable & Accrued Expense Historical Data

The historical data trend for TWi Biotechnology's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TWi Biotechnology Accounts Payable & Accrued Expense Chart

TWi Biotechnology Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

30.21

52.34

24.32

22.85

44.77

TWi Biotechnology Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															21.47	22.85	21.51	44.77	46.30

TWi Biotechnology Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

TWi Biotechnology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » TWi Biotechnology Inc (ROCO:6610) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Lane 221, Kang Chien Road, 8th Floor, Number 41, Neihu District, Taipei, TWN, 11494

Website

http://www.twibiotech.com

TWi Biotechnology Inc is a clinical-stage biopharmaceutical company based in Taiwan. It is engaged in the development of new drugs for unmet medical needs, particularly in the diseases associated with innate immunity. The pipeline products of the company comprise AC-201, AC-203, and AC-701.

TWi Biotechnology Headlines

No Headlines